AFP and hepatocellular carcinoma: It was reported that significant correlations existed between serum PIVKA-II levels and HCC clinicopathological characteristics, such as tumor size and TNM stage [76], and the performance of PIVKA-II plus AFP for HCC identification was superior to each of these biomarkers used alone [78].